Risk factors for neoplastic progression in Barrett’s esophagus

Barrett’s esophagus （BE） confers a significant increased risk for development of esophageal adenocarcinoma （EAC）, with the pathogenesis appearing to progress through a ＂metaplasia-dysplasia-carcinoma＂ （MDC） sequence. Many of the genetic insults driving this MDC sequence have recently been characterized, providing targets for candidate biomarkers with potential clinical utility to stratify risk in individual patients. Many clinical risk factors have been investigated, and associations with a variety of genetic, specific gastrointestinal and other modifiable factors have been proposed in the literature. This review summarizes the current understanding of the mechanisms involved in neoplastic progression of BE to EAC and critically appraises the relative roles and contributions of these putative risk factors from the published evidence currently available.